ALNYLAM PHARMACEUTICALS, INC.
ALNY
34 insider filings · Latest: Jun 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Mar 5 12:29 AM | Yvonne GreenstreetDirector, Chief Executive Officer | Sale | 6,799 | $327.65 | $2.2M | 98,628(D) | View → |
| Mar 3, 2026 | Mar 3 9:49 PM | Fitzgerald Kevin Joseph | Proposed Sale | 1,652 | $321.37 | $530.9K | — | View → |
| Mar 3, 2026 | Mar 3 9:11 PM | Garg Pushkal | Proposed Sale | 1,775 | $321.37 | $570.4K | — | View → |
| Feb 27, 2026 | Mar 2 9:08 PM | Pushkal GargEVP Chief R&D | Sale | 4,627 | $331.34 | $1.5M | 22,129(D) | View → |
| Feb 27, 2026 | Feb 27 9:05 PM | Garg Pushkal | Proposed Sale | 4,627 | $331.34 | $1.5M | — | View → |
| Feb 13, 2026 | Feb 18 12:28 AM | Pushkal GargEVP Chief R&D | Sale | 2,242 | $310.08 | $695.2K | 24,848(D) | View → |
| Feb 13, 2026 | Feb 18 12:27 AM | Yvonne GreenstreetDirector, Chief Executive Officer | Sale | 6,958 | $310.08 | $2.2M | 85,662(D) | View → |
| Feb 13, 2026 | Feb 18 12:27 AM | Tolga TangulerEVP, Chief Commercial Officer | Sale | 1,959 | $310.08 | $607.4K | 31,769(D) | View → |
| Feb 17, 2026 | Feb 18 12:26 AM | Kevin Joseph FitzgeraldCSO & EVP, Head of Research | Sale | 2,041 | $331.96 | $677.5K | 21,264(D) | View → |
| Feb 13, 2026 | Feb 18 12:26 AM | Kevin Joseph FitzgeraldCSO & EVP, Head of Research | Sale | 1,959 | $310.08 | $607.4K | 23,305(D) | View → |
| Feb 13, 2026 | Feb 18 12:26 AM | Jeffrey V. PoultonEVP, Chief Financial Officer | Sale | 2,242 | $310.08 | $695.2K | 59,802(D) | View → |
| Feb 17, 2026 | Feb 17 9:10 PM | Fitzgerald Kevin Joseph | Proposed Sale | 2,041 | $331.96 | $677.5K | — | View → |
| Jan 13, 2026 | Jan 13 9:32 PM | Fitzgerald Kevin Joseph | Proposed Sale | 2,290 | $369.10 | $845.2K | — | View → |
| Nov 17, 2025 | Nov 17 9:04 PM | Fitzgerald Kevin Joseph | Proposed Sale | 12,128 | $449.00 | $5.4M | — | View → |
| Nov 12, 2025 | Nov 12 9:03 PM | Greenstreet Yvonne | Proposed Sale | 25,650 | $453.10 | $11.6M | — | View → |
| Oct 3, 2025 | Oct 3 8:08 PM | Garg Pushkal | Proposed Sale | 3,022 | $451.00 | $1.4M | — | View → |
| Sep 9, 2025 | Sep 9 8:05 PM | Reitan Colleen F | Proposed Sale | 18,000 | $461.12 | $8.3M | — | View → |
| Aug 29, 2025 | Aug 29 8:05 PM | Tanguler Tolga | Proposed Sale | 3,474 | $452.22 | $1.6M | — | View → |
| Aug 19, 2025 | Aug 19 8:03 PM | Garg Pushkal | Proposed Sale | 1,455 | $457.00 | $664.9K | — | View → |
| Aug 18, 2025 | Aug 18 8:08 PM | BONNEY MICHAEL W | Proposed Sale | 11,250 | $450.00 | $5.1M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Jun 3 8:25 PM | I E Pyott DavidDirector | Option Exercise | 3,830 | $70.20 | 0(D) | View → |
| Jun 1, 2026 | Jun 3 8:23 PM | Benjamin CravattDirector | Grant/Award | 4,393 | $295.63 | 4,393(D) | View → |
| May 20, 2026 | May 22 8:20 PM | Charles Elliott SigalDirector | Grant/Award | 1,441 | $298.48 | 1,441(D) | View → |
| May 20, 2026 | May 22 8:18 PM | Amy W SchulmanDirector | Grant/Award | 1,802 | $298.48 | 1,802(D) | View → |
| May 20, 2026 | May 22 8:16 PM | Colleen F ReitanDirector | Grant/Award | 1,441 | $298.48 | 1,441(D) | View → |
| May 20, 2026 | May 22 8:14 PM | I E Pyott DavidDirector | Grant/Award | 1,441 | $298.48 | 1,441(D) | View → |
| May 20, 2026 | May 22 8:12 PM | KELLOGG PETER NDirector | Grant/Award | 1,441 | $298.48 | 1,441(D) | View → |
| May 20, 2026 | May 22 8:11 PM | Margaret A HamburgDirector | Grant/Award | 1,441 | $298.48 | 1,441(D) | View → |
| May 20, 2026 | May 22 8:08 PM | Olivier BrandicourtDirector | Grant/Award | 1,441 | $298.48 | 1,441(D) | View → |
| May 20, 2026 | May 22 8:06 PM | Dennis A AusielloDirector | Grant/Award | 1,441 | $298.48 | 1,441(D) | View → |
| May 20, 2026 | May 22 8:04 PM | Stuart A ArbuckleDirector | Grant/Award | 1,441 | $298.48 | 1,441(D) | View → |
| May 13, 2026 | May 14 8:17 PM | Amy W SchulmanDirector | Option Exercise | 11,250 | $70.20 | 0(D) | View → |
| Mar 2, 2026 | Mar 5 12:31 AM | Jeffrey V. PoultonEVP, Chief Financial Officer | Grant/Award | 10,480 | $325.07 | 10,480(D) | View → |
| Mar 2, 2026 | Mar 5 12:31 AM | Pushkal GargEVP Chief R&D | Grant/Award | 10,480 | $325.07 | 10,480(D) | View → |
| Mar 2, 2026 | Mar 5 12:30 AM | Kevin Joseph FitzgeraldCSO & EVP, Head of Research | Grant/Award | 8,105 | $325.07 | 8,105(D) | View → |
| Mar 2, 2026 | Mar 5 12:30 AM | Tolga TangulerEVP, Chief Commercial Officer | Grant/Award | 10,480 | $325.07 | 10,480(D) | View → |
| Mar 2, 2026 | Mar 5 12:29 AM | Bryan SupranEVP, CLO and Secretary | Grant/Award | 3,381 | $325.07 | 3,381(D) | View → |
| Mar 2, 2026 | Mar 5 12:29 AM | Yvonne GreenstreetDirector, Chief Executive Officer | Grant/Award | 141,171 | $325.07 | 110,746(D) | View → |
| Feb 27, 2026 | Mar 2 9:10 PM | Yvonne GreenstreetDirector, Chief Executive Officer | Option Exercise | 5,921 | — | 0(D) | View → |
| Feb 27, 2026 | Mar 2 9:09 PM | Jeffrey V. PoultonEVP, Chief Financial Officer | Option Exercise | 1,908 | — | 0(D) | View → |
Page 1 of 2
Next →